Catherine Hanaway says Lilly broke its promise to sell discounted medicines to eligible Missouri hospitals by demanding claims data, calling it a violation of state law.
Recap by typeshit. Full story at STAT.
The peptide item sits among gene therapy, Neuralink and Medicare news. The Alliance for Safe Biologic Medicines has asked HHS to pause the policy, citing FDA scientists.
Maria David Patten alleges Novo hid NAION risks; her case joins the federal MDL before Judge Karen Marston in Pennsylvania, where bellwether trials are expected.
HHS now lets pharmacies compound BPC-157, TB-500 and four others, but BoxingInsider notes all six remain on WADA's banned list for licensed boxers.
Politico looks at the warning signs around Health Secretary Kennedy's move to let six peptides that lack FDA approval reach the US market.
The deal brings both the injectable and oral versions of Wegovy straight to employers, another move in the push for workplace GLP-1 coverage.
An FDA panel that includes several peptide sellers recommended four peptides Thursday and one more Friday for pharmacy compounding, while turning down another.
Loading…